Metsera, Inc. — Investor Relations & Filings
Metsera, Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation medicines for obesity and related metabolic diseases. The company's portfolio includes both injectable and oral therapeutic candidates based on nutrient-stimulated hormone (NuSH) analog peptides. Leveraging a proprietary peptide engineering platform, Metsera aims to create potent, ultra-long-acting therapies with improved durability, bioavailability, and manufacturability. The company's approach is designed to deliver scalable treatments, including oral options with injectable-like performance, to enhance effectiveness, tolerability, and long-term patient adherence.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| 15-12G | 2025-11-24 | English | |
| Major Shareholding Notification 2025 | 2025-11-17 | English | |
| 4 | 2025-11-17 | English | |
| STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-11-14 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English |
Browse filings by year
3 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 32333724 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
|
2025
14 filings
| |||||
| 13718408 | 15-12G | 2025-11-24 | English | ||
| 13718409 | Major Shareholding Notification 2025 | 2025-11-17 | English | ||
| 13718410 | 4 | 2025-11-17 | English | ||
| 13718411 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-11-14 | English | ||
| 13718412 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13718413 | Major Shareholding Notification 2025 | 2025-11-13 | English | ||
| 13718414 | 4 | 2025-11-13 | English | ||
| 13718415 | 4 | 2025-11-13 | English | ||
| 13718417 | 4 | 2025-11-13 | English | ||
| 13718416 | 4 | 2025-11-13 | English | ||
| 13718419 | 4 | 2025-11-13 | English | ||
| 13718418 | 4 | 2025-11-13 | English | ||
| 13718420 | 4 | 2025-11-13 | English | ||
| 13718421 | 4 | 2025-11-13 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BIOVIE INC.
Develops drug therapies for neurological disorders and adva…
|
BIVI | US | Manufacturing |
|
BioXcel Therapeutics, Inc.
Biopharmaceutical company using AI to develop drugs for neu…
|
BTAI | US | Manufacturing |
|
Bioxel Pharma Inc.
Develops, manufactures, and markets taxane APIs, essential …
|
— | CA | Manufacturing |
|
BIOXYNE LIMITED
Life sciences company focused on probiotics, medicinal cann…
|
BXN | AU | Manufacturing |
|
B&K CORPORATION LIMITED
Innovative biopharma developing PDGF therapeutic drugs for …
|
2396 | HK | Manufacturing |
|
Black Diamond Therapeutics, Inc.
Develops precision oncology therapies targeting families of…
|
BDTX | US | Manufacturing |
|
BLAU FARMACÊUTICA S.A.
Multinational producer of high-complexity medications for h…
|
— | BR | Manufacturing |
|
Bliss GVS Pharma Limited
Global leader in suppository and pessary production for eme…
|
BLISSGVS | IN | Manufacturing |
|
Blis Technologies Limited
Develops and commercializes patented probiotic strains for …
|
BLT | NZ | Manufacturing |
|
Bloomage Biotechnology Corporation Limited
Global leader in hyaluronic acid and bioactive substance re…
|
688363 | CN | Manufacturing |
Metsera, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30975/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30975 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30975 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30975 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30975}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Metsera, Inc. (id: 30975)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.